Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004
- PMID: 18451806
- DOI: 10.1038/ajh.2008.185
Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004
Abstract
Background: National guidelines recommend the same approach for treating hypertensive men and women. It is not known, however, whether current US antihypertensive medication utilization patterns and the resulting degrees of blood pressure (BP) control are similar or different among hypertensive women and men.
Methods: The study was a cross-sectional, nationally representative survey of the noninstitutionalized civilian US population. Persons aged > or =18 years from the National Health and Nutrition Examination Survey (NHANES) 1999-2004 were classified as hypertensive based on a BP > or =140/90 mm Hg, currently taking antihypertensive medication, or having been diagnosed by a physician.
Results: Among hypertensives, the prevalence of antihypertensive medication use was significantly higher among women than men (61.4% vs. 56.8%), especially among middle-aged persons (40-49 years, 53.1% vs. 42.7%) and among non-Hispanic blacks (65.5% vs. 54.6%). Also, treated women were more likely than men to use diuretics (31.6% vs. 22.3%) and angiotensin receptor blockers (11.3% vs. 8.7%). Among treated hypertensives, the proportion taking three or more antihypertensive drugs was lower among women than men, especially among older persons (60-69 years: 12.3% vs. 19.8%, 70-79 years: 18.6% vs. 21.2%, and > or =80 years: 18.8% vs. 22.8%). Only 44.8% of treated women achieved BP control vs. 51.1% of treated men.
Conclusions: Hypertensive women are significantly more likely to be treated than men, but less likely to have achieved BP control. Additional efforts may be needed to achieve therapeutic goals for the US hypertensive population, especially for hypertensive women.
Similar articles
-
Antihypertensive medication use among US adults with hypertension.Circulation. 2006 Jan 17;113(2):213-21. doi: 10.1161/CIRCULATIONAHA.105.542290. Epub 2006 Jan 3. Circulation. 2006. PMID: 16391156
-
Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.J Hum Hypertens. 2009 Nov;23(11):758-63. doi: 10.1038/jhh.2009.14. Epub 2009 Feb 26. J Hum Hypertens. 2009. PMID: 19242492
-
Lack of control of high blood pressure and treatment recommendations in Canada.Can J Cardiol. 2002 Jun;18(6):657-61. Can J Cardiol. 2002. PMID: 12107423
-
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.Curr Med Res Opin. 2008 Aug;24(8):2389-401. doi: 10.1185/03007990802262457. Epub 2008 Jul 9. Curr Med Res Opin. 2008. PMID: 18616863 Review.
-
Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets?Curr Opin Cardiol. 2011 Jul;26(4):300-7. doi: 10.1097/HCO.0b013e3283474c20. Curr Opin Cardiol. 2011. PMID: 21597369 Review.
Cited by
-
Patient-provider communication, self-reported medication adherence, and race in a postmyocardial infarction population.Patient Prefer Adherence. 2015 Feb 19;9:311-8. doi: 10.2147/PPA.S75393. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25737633 Free PMC article.
-
Eye care utilization by older adults in low, middle, and high income countries.BMC Ophthalmol. 2012 Apr 3;12:5. doi: 10.1186/1471-2415-12-5. BMC Ophthalmol. 2012. PMID: 22471351 Free PMC article.
-
Gender differences in hypertension control among older korean adults: Korean social life, health, and aging project.J Prev Med Public Health. 2015 Jan;48(1):38-47. doi: 10.3961/jpmph.14.043. Epub 2015 Jan 14. J Prev Med Public Health. 2015. PMID: 25652709 Free PMC article.
-
Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications.Front Endocrinol (Lausanne). 2023 Oct 27;14:1295655. doi: 10.3389/fendo.2023.1295655. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37964959 Free PMC article. No abstract available.
-
Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2021 Feb 18;12:614679. doi: 10.3389/fendo.2021.614679. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33679617 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical